Clinical Trial Update: A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)

View source ↗

Summary

This study aims to evaluate the long-term safety of Biogen's multiple sclerosis therapies Vumerity and Tecfidera in people with multiple sclerosis. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)
• VUMERITY (diroximel fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING